DZ Bank downgraded Eli Lilly to Hold from Buy with an $820 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LLY:
- LLY, CVS, EXAS: Which Strong-Buy-Rated Healthcare Stock Is the Better Buy?
- Weight Loss Drugs Are Slimming Down Grocery Bills
- Short Report: Childrenâs Place bears undeterred by Mithaq Capital involvement
- GLP-1 users’ grocery spending declines 6%-9% after starting, says Morgan Stanley
- Eli Lilly price target raised to $950 from $805 at Morgan Stanley